Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
0.737
+0.097 (15.11%)
Nov 5, 2024, 1:19 PM EST - Market open
Athira Pharma Stock Forecast
ATHA's stock price has decreased by -55.46% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Athira Pharma stock have an average target of 11.25, with a low estimate of 0.50 and a high estimate of 22. The average target predicts an increase of 1,426.46% from the current stock price of 0.74.
Analyst Consensus: Buy
* Price targets were last updated on Sep 19, 2024.
Analyst Ratings
The average analyst rating for Athira Pharma stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 2 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Mizuho | Mizuho | Buy → Hold Downgrades $5 → $0.5 | Buy → Hold | Downgrades | $5 → $0.5 | -32.16% | Sep 19, 2024 |
JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Sep 4, 2024 |
BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 4, 2024 |
Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +2,885.07% | Aug 19, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $19 | Buy | Reiterates | $19 | +2,478.02% | Jun 20, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.60
from -3.09
EPS Next Year
-1.66
from -2.60
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | ||
Avg | n/a | n/a | n/a | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -2.18 | -0.69 | -0.86 |
Avg | -2.60 | -1.66 | -0.86 |
Low | -2.72 | -3.21 | -0.86 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.